The Efficacy of the Combination Treatment of Repaglinide and Metformin for Diabetes
Ya Li
Abstract
Ya Li
Abstract
Objective:To investigate the efficacy of the combination treatment of Repaglinide and Metformin for diabetes.Method:260 cases diagnosed with type 2 diabetes were randomly divided into combined treatment group(Repaglinide+Metformin Hydrochloride) 100 cases,80 cases of Repaglinide group and 80 patients of Metformin Hydrochloride group,the clinical treatment results were compared.Result:The FBG,HbA1c of the combination group before and after the treatment were significantly decreased,compared with the Repaglinide group or Metformin group,there were statistical significance(P0.05).Conclusion:The combination therapy is effective for type 2 diabetes.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the efficacy of the combination treatment of Repaglinide and Metformin for diabetes.Method:260 cases diagnosed with type 2 diabetes were randomly divided into combined treatment group(Repaglinide+Metformin Hydrochloride) 100 cases,80 cases of Repaglinide group and 80 patients of Metformin Hydrochloride group,the clinical treatment results were compared.Result:The FBG,HbA1c of the combination group before and after the treatment were significantly decreased,compared with the Repaglinide group or Metformin group,there were statistical significance(P0.05).Conclusion:The combination therapy is effective for type 2 diabetes.
Key concepts: Repaglinide, Medicine, Metformin, Type 2 diabetes, Metformin Hydrochloride, Diabetes mellitus, Internal medicine, Statistical significance